The largest retrospective, observational study comparing two osteoporosis therapies on the basis of fracture reduction was presented today at the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) in Porto, Portugal.
Pharmaceutical manufacturers and their trade groups spent a record $155 million lobbying the federal government and its agencies from January 2005 to June 2006, according to a Center for Public Integrity report based on data obtained from the Senate Office of Public Records.
New Mexico now joins Alaska, California, Colorado, Hawaii, Maine, Montana, Nevada, Oregon, Rhode Island, Vermont and Washington in protecting medical marijuana patients from arrest.
A new report released by the Institute of Medicine (IOM) shows that the fight against AIDS is being undermined by the requirement that most US funding to address sexual transmission of HIV go to abstinence-until-marriage programs.
Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week.
The benefits of full-scale adoption of health information technology (HIT) will be significant, leading to a higher standard of quality in the U.S. health care system, Lynne M. Kirk, MD, FACP, president of the American College of Physicians (ACP), today told a hearing of the Subcommittee on Regulations, Healthcare and Trade of the House Committee on Small Business.
Effective postoperative pain control using continuous peripheral nerve block reduced average length-of-stay by nearly a day, University of Pittsburgh School of Medicine physicians reported during the 81st Clinical and Scientific Congress of the International Anesthesia Research Society at the Buena Vista Palace in Orlando, Fla.
Harvard Medical School researchers are working on a new, simpler way to distinguish malignant tumors from non-cancerous masses when screening for breast cancer.
The U.S. Food and Drug Administration (FDA) recently submitted to Congress its final proposal for reauthorizing the Prescription Drug User Fee Act (PDUFA IV) after reviewing public comments.
Many Australian adults are enjoying improved oral health, but some are still missing out, according to a report by the Australian Institute of Health and Welfare (AIHW) launched by the Hon Tony Abbott at the 32nd Australian Dental Congress in Sydney.